← Leaderboards
Jian Feng
State University Of New York At Buffalo
$11,044,719
Attributed
$13,285,320
Total exposure
12
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2006–25$2.5M$1.9M$1.3M$625K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,285,320 · 9
VA$0 · 3
By mechanism
R01$11,553,176 · 6
P01$894,769 · 1
R21$438,625 · 1
R56$398,750 · 1
I01$0 · 2
IS1$0 · 1
Top collaborators
- Zhen Yan8 shared
Most similar at State University Of New York At Buffalo
Same institution · by research overlap
- Zhen Yan$22,366,472
Others in their field
Top investigators on “Neurons”
- Hongkui Zeng · Allen Institute$106,358,289
- Eric Martin McDade · Washington University$94,632,845
- Ed Lein · Allen Institute$90,858,363
- Randall J Bateman · Washington University$65,841,935
- John Morris · Washington University$65,018,684
- Paul S. Aisen · Cognition Therapeutics, Inc.$58,570,460
Research focus
NeuronsCellsGenesInsightMolecularDopaminergic NeuronAffectInduced Pluripotent Stem CellBaseGeneticGene ExpressionAlzheimer&AposLinkIn VivoParkinson DiseaseFibroblastsBrainDopaminePlayExhibitsTissuesPropertyCell TypePreparation
Grant awards (46)
Transcriptomic and Circuitry Aberrations in Alzheimerâs Disease$728,217
R01 · FY2025 · AG
Epigenetics-Based Autism Treatment with Animal Models and Human Stem Cells$618,417
R01 · FY2025 · NS
Transcriptomic and Circuitry Aberrations in Alzheimerâs Disease$741,733
R01 · FY2024 · AG
Epigenetics-Based Autism Treatment with Animal Models and Human Stem Cells$599,088
R01 · FY2024 · NS
Molecular Segregation of Parkinsonâs Disease by Patient-Derived Neurons$435,515
R01 · FY2024 · NS · contact PI
Transcriptomic and Circuitry Aberrations in Alzheimerâs Disease$739,425
R01 · FY2023 · AG
Epigenetics-Based Autism Treatment with Animal Models and Human Stem Cells$615,697
R01 · FY2023 · NS
Molecular Segregation of Parkinsonâs Disease by Patient-Derived Neurons$448,985
R01 · FY2023 · NS · contact PI
Administrative Supplement to Molecular Segregation of Parkinsonâs Disease by Patient-derived Neurons$401,250
R01 · FY2023 · NS · contact PI
Molecular Segregation of Parkinsonâs Disease by Patient-derived Neurons$448,985
R01 · FY2022 · NS · contact PI
Functions of parkin in Parkinsonâs disease$450,326
R01 · FY2021 · NS · contact PI
Molecular Segregation of Parkinsonâs Disease by Patient-derived Neurons$448,985
R01 · FY2021 · NS · contact PI
New Treatment Strategy for Alzheimerâs Disease$239,250
R21 · FY2021 · AG · contact PI
The Interaction of parkin and environmental toxins in Parkinsonâs disease$0
I01 · FY2021 · VA · contact PI
Kinetic Barriers of Transdifferentiation$0
I01 · FY2021 · VA · contact PI
Functions of parkin in Parkinsonâs disease$450,326
R01 · FY2020 · NS · contact PI
Molecular Segregation of Parkinsonâs Disease by Patient-derived Neurons$448,985
R01 · FY2020 · NS · contact PI
New Treatment Strategy for Alzheimerâs Disease$199,375
R21 · FY2020 · AG · contact PI
The Interaction of parkin and environmental toxins in Parkinsonâs disease$0
I01 · FY2020 · VA · contact PI
Kinetic Barriers of Transdifferentiation$0
I01 · FY2020 · VA · contact PI
Functions of parkin in Parkinsonâs disease$450,326
R01 · FY2019 · NS · contact PI
Kinetic Barriers of Transdifferentiation$0
I01 · FY2019 · VA · contact PI
The Interaction of parkin and environmental toxins in Parkinsonâs disease$0
I01 · FY2019 · VA · contact PI
Functions of parkin in Parkinsonâs disease$450,326
R01 · FY2018 · NS · contact PI
Kinetic Barriers of Transdifferentiation$0
I01 · FY2018 · VA · contact PI
The Interaction of parkin and environmental toxins in Parkinsonâs disease$0
I01 · FY2018 · VA · contact PI
Functions of parkin in Parkinsonâs disease$398,750
R56 · FY2017 · NS · contact PI
Kinetic Barriers of Transdifferentiation$0
I01 · FY2017 · VA · contact PI
Kinetic Barriers of Transdifferentiation$0
I01 · FY2016 · VA · contact PI
ShEEP Request for Nikon Biostation CT System$0
IS1 · FY2016 · VA · contact PI
Kinetic Barriers of Transdifferentiation$0
I01 · FY2015 · VA · contact PI
Kinetic Barriers of Transdifferentiation$0
I01 · FY2014 · VA · contact PI
Cellular Functions of Parkin$327,892
R01 · FY2013 · NS · contact PI
Cellular Functions of Parkin$339,784
R01 · FY2012 · NS · contact PI
Cellular Functions of Parkin$339,784
R01 · FY2011 · NS · contact PI
Cellular Functions of Parkin$343,252
R01 · FY2010 · NS · contact PI
THE ROLE OF DMP1 IN OSTEOCYTE FUNCTION$211,454
P01 · FY2010 · AR · contact PI
Cellular Functions of Parkin$346,719
R01 · FY2009 · NS · contact PI
THE ROLE OF DMP1 IN OSTEOCYTE FUNCTION$210,524
P01 · FY2009 · AR · contact PI
THE ROLE OF DMP1 IN OSTEOCYTE FUNCTION$168,885
P01 · FY2008 · AR · contact PI
THE ROLE OF DMP1 IN OSTEOCYTE FUNCTION$137,032
P01 · FY2007 · AR · contact PI
THE ROLE OF DMP1 IN OSTEOCYTE FUNCTION$166,874
P01 · FY2006 · AR · contact PI
Parkin--In vivo Function and Role in Parkinson's Disease$353,250
R01 · FY2004 · NS
Parkin--In vivo Function and Role in Parkinson's Disease$349,283
R01 · FY2003 · NS
Parkin--In vivo Function and Role in Parkinson's Disease$344,863
R01 · FY2002 · NS
Parkin--In vivo Function and Role in Parkinson's Disease$331,763
R01 · FY2001 · NS